Management of Osteoporosis after Transplantation
This presentation will focus on presenting evidence-based information regarding the epidemiology, pathophysiology, diagnosis, assessment, pharmacological management and monitoring of patients with, or at risk for post-transplant osteoporosis. Exposure to this specific population of transplant patients may differ between pharmacists, but it is necessary that all pharmacists understand how to manage this disease state, as a variety of patient populations can be affected by glucocorticoid-induced bone disease. This presentation will incorporate interactive learning questions and case-based application questions to engage pharmacists in an active learning method.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Describe the risk factors for and diagnosis of patients with post-transplant osteoporosis
- Analyze the literature supporting the use of pharmacologic agents in prevention and treatment of post-transplant osteoporosis
- Design a therapeutic regimen including non-pharmacological and pharmacological modalities for management of post-transplant osteoporosis
Pharmacy technician learning objectives
- Identify the pharmacological options for the management of post-transplant osteoporosis
- Recognize the dosage forms of the medications used for management of post-transplant osteoporosis
Additional Information
Attachment | Size |
---|---|
![]() | 23.3 KB |
![]() | 123.13 KB |

Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CEU – Attendance